Article Versions Notes

Schepisi G, Casadei C, Toma I, Poti G, Iaia ML, Farolfi A, Conteduca V, Lolli C, Ravaglia G, Brighi N, et al. Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy. Cancers. 2021; 13(4):840. https://doi.org/10.3390/cancers13040840

Schepisi, Giuseppe, Chiara Casadei, Ilaria Toma, Giulia Poti, Maria Laura Iaia, Alberto Farolfi, Vincenza Conteduca, Cristian Lolli, Giorgia Ravaglia, Nicole Brighi, and et al. 2021. "Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy" Cancers 13, no. 4: 840. https://doi.org/10.3390/cancers13040840

Schepisi, G., Casadei, C., Toma, I., Poti, G., Iaia, M. L., Farolfi, A., Conteduca, V., Lolli, C., Ravaglia, G., Brighi, N., Altavilla, A., Martinelli, G., & De Giorgi, U. (2021). Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy. Cancers, 13(4), 840. https://doi.org/10.3390/cancers13040840